The First Trust Large Cap Core AlphaDEX Fund is a passively managed exchange-traded fund that tracks a multi-factor enhanced index of 375 large-cap U.S. stocks, and its investment case rests on the persistent outperformance of a value-growth blended factor strategy in a broad equity market.
The most important recent development is the fund's sustained outflow of approximately $33 million over the trailing twelve months. This pattern reflects the broader industry trend of investors rotating from enhanced index funds toward lower-cost passive alternatives and concentrated active strategies that promise more differentiated alpha. The outflow compresses the fund's asset base and, by extension, the fee revenue available to cover its 0.57% expense ratio, creating a slow but persistent drag on net returns for remaining shareholders.
The central tension in the investment case is that the AlphaDEX methodology has delivered solid risk-adjusted returns over its full history, yet the fund's cost structure places it in the second-cheapest quintile among peers only by a narrow margin. The strategy's historical alpha has also eroded in recent years relative to its index, and the 10-year tracking difference of 441 basis points is a reminder that the factor tilt can produce sustained underperformance in the wrong market environment.
The catalyst to watch is the expiration of the current expense cap agreement in late 2026. That date could prompt a fee reduction announcement or a decision by First Trust to let the cap lapse and allow expenses to rise toward the contractual ceiling.
The Fund operates as a series of the First Trust Exchange-Traded AlphaDEX Fund, a legal structure that allows First Trust Portfolios L.P. to offer a family of enhanced index ETFs under a single trust umbrella. First Trust Advisors L.P. serves as investment advisor, and Bank of New York Mellon Corp. acts as investor servicing agent. The fund's business model is to charge an annual expense ratio of 0.57% to track the Nasdaq AlphaDEX Large Cap Core Index. The index selects 375 stocks from the Nasdaq Large Cap 500 universe using a proprietary multi-factor scoring system that blends growth and value criteria.
The fund's competitive position within the enhanced index ETF space is defined by three variables: the quality of the AlphaDEX selection methodology, the expense ratio relative to peers, and the scale of assets under management. With approximately $1.6 billion in net assets, the fund sits in the mid-range of the enhanced large-cap ETF category, large enough to benefit from economies of scale in trading and portfolio management but small enough to remain vulnerable to the outflow trends that have affected the broader ETF industry. The fund's 10-year annualized return sits well below the index return over the same period. The gap reflects both the expense ratio drag and the variable performance of the AlphaDEX tilt across different market regimes, and the fund's 9.72% figure trails the index's 14.13% by a wide margin.
The fund's parent company, First Trust, has expanded its product lineup significantly over the past decade, and the AlphaDEX series represents a core pillar of the enhanced index offering. The AlphaDEX methodology is a registered trademark of First Trust Portfolios L.P., which has licensed it to Nasdaq, Inc. for use in the index. This licensing arrangement means that the index is maintained and owned by Nasdaq, while the selection methodology remains under First Trust's intellectual property control. The fund's quarterly rebalance frequency drives a portfolio turnover rate of 83%, which is materially higher than the turnover of a standard cap-weighted index fund and contributes to higher transaction costs and potential tax inefficiencies for shareholders holding the fund in taxable accounts.
The fund's distribution of assets across sectors reflects the composition of the underlying index rather than any active tilting by the advisor. As of the most recent reporting, the portfolio is concentrated in Financials at roughly 19% and Electronic Technology at roughly 15%. Industrials add another 18%, and the remainder spreads across Healthcare, Consumer Discretionary, Utilities, Energy, and Real Estate. This sector allocation is broadly in line with the large-cap U.S. equity market, though the AlphaDEX selection process introduces modest deviations from cap-weighted sector weights based on the factor scores of the constituent stocks.
The AlphaDEX selection methodology is the core intellectual property underlying the fund's investment strategy. The methodology begins with the 500 stocks in the Nasdaq Large Cap 500 Index, removes duplicates and illiquid names, and then ranks the remaining stocks on both growth factors and value factors. Growth factors include short-term and long-term price appreciation, sales-to-price ratios, and one-year sales growth. Value factors include book value to price, cash flow to price, and return on assets. Each stock is classified as either a value stock or a growth stock based on Nasdaq's style designation, and the stock's selection score is determined by its rank on the applicable factor set.
The moat for this fund is intellectual property based rather than operational. First Trust Portfolios L.P. holds the patent for the AlphaDEX stock selection methodology, which was granted by the United States Patent and Trademark Office. This patent protects the specific algorithmic process used to rank and select stocks, and it prevents other fund sponsors from replicating the exact selection process without a licensing agreement. However, the moat is narrower than it appears on the surface because the methodology is a rules-based screen that applies well-known factor dimensions, and competitors can achieve similar factor tilts through different weighting schemes, different factor definitions, or different universe constructions. The 10-year performance gap between the fund and its index suggests that the alpha generated by the selection process has not been sufficient to offset the expense ratio and transaction costs over the full cycle.
The fund's technology infrastructure is standard for a passively managed ETF. The portfolio is rebalanced quarterly in line with the index reconstitution schedule, and trading is executed to minimize tracking error while managing the costs of the 83% annual turnover rate. The fund does not employ derivatives for replication or hedging, and it holds no short positions. The physical replication approach means that the fund's performance tracks the index closely, with tracking differences driven primarily by the expense ratio, transaction costs, and the timing of rebalancing trades. The fund's average daily volume of approximately 25,000 shares indicates adequate liquidity for most retail and institutional investors, though the bid-ask spread is wider than that of the largest and most liquid U.S. equity ETFs.
The fund's dividend distribution is a pass-through of the dividends received from the underlying portfolio stocks, net of the fund's operating expenses. The fund pays quarterly distributions, with the most recent distribution of $0.27 per share paid in June of 2026. The 12-month distribution rate of roughly 0.94% is in line with the dividend yield of the large-cap U.S. equity market, and the distribution is subject to variation based on the composition of the portfolio and the level of dividends paid by the constituent stocks. The fund's SEC yield of approximately 1.15% reflects the expected cash return from the portfolio's dividend-paying holdings, net of expenses.
The fund's financial performance is best understood as the performance of the underlying index minus the expense ratio and transaction costs. The fund's NAV total return for the trailing 12 months is 19.96%, trailing the index by a modest margin. The tracking difference reflects the expense ratio and the costs associated with the quarterly rebalancing process, and it is consistent with the fund's historical tracking behavior over shorter time horizons.
The fund's annualized returns over longer periods reveal a more complex picture. The 5-year annualized NAV return of 11.70% trails the index by a margin roughly in line with the expense ratio. The 10-year annualized NAV return of 9.72% trails the index by a wide margin. That larger gap suggests that the AlphaDEX tilt underperformed the cap-weighted index over the most recent decade. This underperformance is driven primarily by the performance of the value stocks selected by the AlphaDEX methodology during the growth-dominated market conditions of 2019 through 2021.
The fund's expense structure is fixed at 0.57% under the current agreement. The advisor agrees to waive fees to the extent that operating expenses exceed a contractual cap through the end of 2026. The 0.57% figure is composed of a 0.50% management fee and a small amount in other expenses. There are no 12b-1 distribution or service fees. The expense cap provides a ceiling on the fund's operating costs, but it also means that any reduction in the expense ratio would require a new agreement between the advisor and the trust.
The fund's portfolio turnover of 83% is a significant cost driver that is not captured in the expense ratio. The quarterly rebalancing process requires the fund to buy and sell a substantial portion of its holdings each quarter, and the transaction costs associated with these trades are borne by the fund and, by extension, by its shareholders. The 83% turnover rate is roughly in line with the average turnover of enhanced index ETFs, but it is materially higher than the turnover of a standard cap-weighted index fund, which typically turns over less than 5% of its portfolio annually.
The fund's forward outlook is shaped by three variables: the persistence of the AlphaDEX methodology's alpha, the trajectory of the fund's asset base, and the competitive dynamics in the enhanced index ETF space. The AlphaDEX methodology has a long track record dating back to the fund's inception in 2007, and its performance has varied by market regime. In value-favorable environments, the methodology has generated positive alpha relative to the cap-weighted index, while in growth-dominated environments, the value tilt has produced underperformance.
The fund's asset base has been declining over the trailing twelve months, with net outflows of approximately $33 million. This outflow pattern is consistent with the broader industry trend of investors moving from enhanced index funds toward lower-cost passive alternatives, and it reflects the increasing availability of zero-fee and low-fee index funds that track the same large-cap U.S. equity universe without the factor tilt. The outflow compresses the fund's fee revenue and, if sustained, could eventually force the advisor to reduce the expense ratio to remain competitive or to consider merging the fund with a larger sibling in the AlphaDEX family.
The execution risk for the fund is low relative to an actively managed fund because the portfolio is passively constructed to replicate the index. The primary execution risks are tracking error from the rebalancing process, the availability of authorized participants to facilitate creation and redemption transactions, and the operational risk associated with the quarterly rebalancing trades. The fund's average daily volume of approximately 25,000 shares indicates that the fund is sufficiently liquid to accommodate the creation and redemption activity that maintains the arbitrage mechanism between the fund's market price and its net asset value.
The upcoming expiration of the expense cap agreement is a near-term catalyst that could affect the fund's cost structure. The decision on the cap is expected to be made in the months leading up to the deadline, and it is likely to be influenced by the fund's asset base trajectory and the competitive dynamics in the enhanced index ETF space. If First Trust chooses to extend the cap at the current level, the fund's cost structure remains unchanged. If the advisor allows the cap to lapse, the expense ratio could rise toward the contractual ceiling, which would increase the drag on shareholder returns.
The primary risk for the fund is the persistent underperformance of the AlphaDEX methodology relative to the underlying index. The 10-year tracking difference of 441 basis points, in which the fund underperformed the index by a margin substantially larger than the expense ratio, is a warning that the factor tilt can produce sustained underperformance in the wrong market environment. If the market returns to a growth-dominated regime in which the largest technology companies continue to outperform value stocks, the AlphaDEX value tilt would hold the fund back relative to a cap-weighted benchmark, and the tracking difference would widen further.
The second major risk is the continued outflow of assets, which would compress the fund's fee revenue and could eventually force a reduction in the expense ratio or a merger with a larger fund. The $33 million in trailing twelve-month outflows represent roughly 2% of the fund's asset base, a rate that is not alarming in the short term but that would be significant if sustained over a multi-year period. A 10% annual outflow rate would reduce the fund's assets to approximately $1.2 billion within three years, a level at which the fund's fee revenue would be insufficient to cover the fixed costs of portfolio management and compliance.
The third risk is the concentration of the fund's holdings in a relatively small number of large-cap stocks. The portfolio's top 10 holdings represent approximately 5% of the total portfolio. The largest individual position is roughly 0.66% of net assets. This level of concentration is low relative to a cap-weighted index fund, in which the top 10 holdings can represent 30% or more of the portfolio, but it is higher than the effective concentration of a truly equal-weighted fund. The concentration risk is mitigated by the quarterly rebalancing process, which prevents any single stock from becoming a dominant position.
The fourth risk is the operational risk associated with the quarterly rebalancing process. The 83% turnover rate means that the fund is executing a large volume of trades each quarter, and any operational failure in the trading process would increase the fund's tracking error and potentially affect its tax efficiency. The fund's use of a physical replication approach means that it does not face the counterparty risk associated with a synthetic replication approach, but it does face the market risk associated with executing a large number of trades in a short period.
The valuation of an exchange-traded fund is fundamentally different from the valuation of an operating company. The fund's shares trade at a price that is determined by the arbitrage mechanism between the creation and redemption process and the secondary market, and the price converges to the fund's net asset value over time. The fund's current market price of approximately $135 per share is in close alignment with its NAV of roughly the same level, with a discount or premium of less than 0.1% in recent trading.
The expense ratio is the primary cost consideration for investors, and it can be benchmarked against the rates charged by comparable enhanced index ETFs. The fund's 0.57% rate is in the second-cheapest quintile among peers, with a median peer rate of approximately 0.59%. The fund's cost advantage is modest, and it is vulnerable to erosion if competitors reduce their rates or if the fund's own rate rises after the cap expiration in late 2026. The fund's expense ratio of 0.57% compares to rates as low as 0.03% for the largest passive index ETFs. That gap is substantial in absolute terms.
The fund's performance-based valuation can be assessed by comparing its risk-adjusted returns to those of its index and to those of its peer group. The fund's 10-year annualized return of 9.72% trails the index return. It also sits below the peer group median, placing the fund in the second quartile of the peer group over the 10-year period. The fund's 5-year annualized return of 13.43% trails the index return as well, placing the fund in the third quartile over the same period. The fund's information ratio relative to its index has been positive but modest over the full history, indicating that the AlphaDEX methodology has generated some positive alpha but not enough to justify the expense ratio on a risk-adjusted basis over the full cycle.
The bear case assumes the AlphaDEX methodology continues to underperform the index by the 10-year average tracking difference. Under these assumptions, the fund's annualized return would be in the low single digits over the next decade. The base case assumes the methodology generates alpha in line with its 5-year performance and that the asset base is stable. The expense ratio remains unchanged, producing a mid-teens annualized return over the next decade. The bull case assumes a value-favorable market environment and a fee reduction. With modest annual asset growth, the fund produces a high-teens annualized return over the next decade.
The First Trust Large Cap Core AlphaDEX Fund is a well-constructed enhanced index ETF with a long track record, a defensible intellectual property moat, and a cost structure that is competitive but not dominant within its peer group. The fund's 10-year underperformance relative to its index is the central weakness in the investment case, and it raises a legitimate question about whether the AlphaDEX methodology's alpha is sufficient to justify the expense ratio on a risk-adjusted basis over a full market cycle. The fund's current asset base of approximately $1.6 billion is large enough to sustain operations indefinitely, but the trailing twelve-month outflow of $33 million is a signal that the fund is losing share in a competitive market.
The investment case for the fund is strongest for investors who have a specific preference for a multi-factor enhanced index approach, who are willing to accept a modest cost premium relative to a passive index fund in exchange for the potential of positive alpha, and who have a long enough investment horizon to allow the factor timing risk to average out over multiple market regimes. The fund's quarterly rebalancing process and its physical replication approach provide a degree of transparency and operational predictability that is absent from more complex enhanced index strategies, and the fund's negligible discount to NAV and adequate trading liquidity indicate that the arbitrage mechanism is functioning as intended.
The counterargument to the investment case is that the fund's 10-year tracking difference of 441 basis points is too large to be explained by the expense ratio alone, and that the AlphaDEX methodology's value tilt has systematically underperformed in the growth-dominated market environment that has prevailed for much of the past decade. An investor who has no specific preference for a multi-factor enhanced index approach and who is willing to accept the full market risk of the large-cap U.S. equity universe is likely to achieve a higher after-cost return from a low-cost passive index fund than from this fund, all else being equal.
The final judgment is that the fund is a reasonable holding for investors who already have a conviction about the long-term persistence of the AlphaDEX methodology's alpha and who are seeking a transparent, liquid, and operationally sound vehicle for that exposure. The fund's November 2026 expense cap expiration is a near-term catalyst that warrants monitoring, and the fund's asset base trajectory is a variable that should be tracked on a quarterly basis to assess whether the outflow pattern is accelerating or stabilizing. The fund is not a high-conviction buy on current fundamentals, but it is not a clear sell either, and the appropriate action for existing holders is to hold and monitor the expense cap decision and the asset base trajectory over the coming two to three quarters.